# Eversense and Dexcom G5: Efficacy and Accuracy in Type 1 Diabetic Patients

> **NCT03613805** · NA · COMPLETED · sponsor: **University of Padova** · enrollment: 16 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DEVICE:** Dexcom G5-Eversense
- **DEVICE:** Eversense-Dexcom G5

## Key facts

- **NCT ID:** NCT03613805
- **Lead sponsor:** University of Padova
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-14
- **Primary completion:** 2018-12-31
- **Final completion:** 2019-09-01
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2020-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03613805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03613805, "Eversense and Dexcom G5: Efficacy and Accuracy in Type 1 Diabetic Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03613805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*